The Vaccine

The rapid development of the COVID 19 vaccine has both its promoters and detractors. Regardless where one might fall on this spectrum there are many who may wonder what changes were made in the pharmaceutical development process that enabled the COVID 19 vaccine to rapidly come to market. In this episode we explore the pharmaceutical development process and merits of the COVID 19 vaccine with Keith Watts DBA, Principal of pharmaceutical and healthcare consulting organization Talexto Health Care Strategies.

Leave a Reply